Neuroprotection and selective vulnerability of neurons within the nucleus basalis magnocellularis

Behavioural Brain Research

Volumn 72, Issue 1-2, 1995, Pages 17-24

  Wenk, Gary L ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Acetylcholine; Cytotoxicity; Glutamate; N methyl d aspartate (NMDA); Neuroprotection; Nucleus basalis; Selective vulnerability

Indexed keywords

GLUTAMIC ACID; IBOTENIC ACID; KAINIC ACID; N METHYL DEXTRO ASPARTIC ACID; NEUROTOXIN; QUINOLINIC ACID;

AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; MAGNOCELLULAR NUCLEUS; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMAL; BASAL GANGLIA; HUMAN; NEURONS; NEUROTRANSMITTERS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0029655903     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-4328(96)00152-0     Document Type: Review

References (87)

1. Cholecystokinin blocks some effects of kainic acid in CA3 region of hippocampal slices
2. Nicotine-induced protection of cultured cortical neurons against N-methyl-d-aspartate receptor-mediated glutamate cytotoxicity
3. Differential effect of kainic acid on somatostatin, gabaergic and cholinergic neurons in the rat striatum
4. The cholinergic hypothesis of geriatric memory dysfunction
5. Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions
6. Nitric oxide, a novel neuronal messenger
7. Increased excitotoxic vulnerability of cortical cultures with reduced levels of glutathione
8. Sensitivity to H, Li and Mg ions of the slow inward sodium current in frog atrial fibres
9. Activation of metabotropic receptors has a neuroprotective effect in a rodent model of focal ischaemia
10. Ionic dependence of glutamate neurotoxicity
11. Glutamate neurotoxicity and diseases of the nervous system
12. Methods for antagonizing glutamate neurotoxicity
13. Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists
14. Behavioral impairments after lesions of the nucleus basalis by ibotenic acid and quisqualic acid
15. Alzheimer's disease: a disorder of cortical cholinergic innervation
16. The use of excitatory amino acids as selective neurotoxins
17. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures
18. A novel neuronal messenger molecule in brain: the free radical, nitric oxide
19. Efficacy and tolerability of memantine in patients with dementia syndrome
20. The basal forebrain-cortical cholinergic system: interpreting the function consequences of excitotoxic lesions
21. Behavioral, Biochemical and Histochemical effects of different neurotoxic amino acids injected into nucleus basalis magnocellularis of rats
22. Memantine is highly potent in protecting cortical cultures against excitotoxic cell death evoked by glutamate and N-methyl-d-aspartate
23. Excitatory amino acid receptors, neural membrane phospholipid metabolism and neurological disorders
24. Neonatal striatal NADPH-diaphorase neurons are vulnerable to quisqualate and its analogue alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)
25. 2-Chloroadenosine attenuates NMDA, kainate, and quisqualate toxicity
26. Possible role of cGMP in excitatory amino acid induced cytotoxicity in cultured cerebral cortical neurons
27. 2+ of N-methyl-d-aspartate and quisqualate neurotoxicity in young rat hippocampal slices
28. AMPA neurotoxicity in rat cerebellar and hippocampal slices: histological evidence for three mechanisms
29. Glutamate toxicity: an experimental and theoretical analysis
30. Memantine in the treatment of mild to moderate dementia syndrome
31. Oxidants and the central nervous system some fundamental questions
32. Differential vulnerability of basal forebrain cholinergic and NADPH-diaphorase cells
33. Nitric oxide does not underlie the memory deficits produced by ibotenate injections into the nucleus basalis
34. Neuroprotective effects of glutamate antagonists and extracellular acidity
35. Memantine prevents quinolinic acid-induced hippocampal damage
36. Glutamate receptor agonists nitric oxide synthase in primary cultures of cerebellar granule cells
37. Vulnerability of cultured cortical neurons to damage by excitotoxins: differential susceptibility of neurons containing NADPH-diaphorase
38. Zinc alters excitatory amino acid neurotoxicity on cortical neurons
39. A metabotropic glutamate receptor agonist does not mediate neuronal degeneration in cortical culture
40. Activation of the metabotropic glutamate receptor attenuates N-methyl-d-aspartate neurotoxicity in cortical cultures
41. Contributory mechanisms in the causation of neurodegenerative disorders
42. Ascorbic acid protects neurons from injury induced by glutamate and NMDA
43. Nucleus basalis magnocellularis and memory: differential effects of two neurotoxins
44. Acetylcholine potentiates glutamate-induced neurodegeneration in cultured hippocampal neurons
45. Neuroprotective synergism of 2-amino-3-phosphonoproprionate (DL-AP3) and MK-801 against ibotenate induced brain injury
46. Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area diagonal band nuclei, nucleus basalis (substantia innominata) and hypothalamus in the rhesus monkeys
47. The excitotoxin quinolinic acid is present in the brain of several mammals and its cortical content increases during the aging process
48. Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress
49. Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake
50. Comparative toxicity of kainic acid and other acidic amino acids toward rat hippocampal neurons
51. The influence of hydrogen ion concentration on calcium binding and release by skeletal muscle sarcoplasmic reticulum
52. Excitatory amino acids and neuropsychiatric disorders
53. Dementia: animal models of the cognitive impairments produced by degeneration of the basal forebrain cholinergic system
54. Dissociable effects on spatial maze and passive avoidance acquisition and retention following AMPA- and ibotenic acid-induced excitotoxic lesions of the basal forebrain in rats: Differential dependence on cholinergic neuronal loss
55. Galanin and NADPH-diaphorase coexistence in cholinergic neurons of the rat basal forebrain
56. Quinolinic acid: regional variations in neuronal sensitivity
57. Zinc selectivity blocks the action of N-methyl-d-aspartate on cortical neurons
58. Dissociation of nitric oxide generation and kainate-mediated neuronal degeneration in primary cultures of rat cerebellar granule cells
59. Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson's disease
60. Stimulation of phosphoinositol hydrolysis by ibotenic acid in cerebellar neurons via two glutamate receptor subtypes
61. Comparison of quisqualic and ibotenic acid nucleus basalis magnocellularis lesions on water-maze and passive avoidance performance
62. Comparative effects of ibotenic acid- and quisqualic acid-induced lesions of the substantia innominata on attentional function in the rat: further implications for the role of the cholinergic neurons of the nucleus basalis in cognitive processes
63. Excitotoxicity and the NMDA receptor
64. Cortical projections arising from the basal forebrain: a study of cholinergic and noncholinergic components employing combined retrograde tracing and immunohistochemical localization of choline acetyltransferase
65. Nucleus basalis lesions impair memory in rats trained on nonspatial and spatial discrimination tasks
66. Dissociative effects of ibotenic and quisqualic acid-induced basal forebrain lesions on cortical acetylcholinesterase-positive fiber density and cytochrome oxidase activity
67. Demonstration of a unique population of neurons with NADPH-diaphorase histochemistry
68. Excitatory amino acid agonist-antagonist interactions at 2-amino-4-phosphonobutyric acid-sensitive quisqualate receptors coupled to phosphoinositide hydrolysis in slices of rat hippocampus
69. Differential vulnerability of central neurons of the rat to quinolinic acid
70. Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain
71. Activation of the glutamate metabotropic receptor protects retina against N-methyl-d-aspartate toxicity
72. Effects of NBM lesions with two neurotoxins on spatial memory and autoshaping
73. Neuropharmacology of quinolinic and kynurenic acids
74. Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS
75. Kangenkaryu prevents the decrease of cholinergic markers following the nucleus basalis magnocellularis lesion
76. SUT-8701, a cholecystokinin analog, prevents the cholinergic degeneration in the rat cerebral cortex following basal forebrain lesioning
77. Neurons that say NO
78. Histochemical mapping of nitric oxide synthase in the rat brain
79. Differential sensitivity of calbindin and parvalbumin immunoreactive cells in the striatum to excitotoxins
80. Nucleus basalis magnocellularis: optimal coordinates for selective reduction of choline acetyltransferase in frontal neocortex by ibotenic acid injections
81. Investigations of neurotoxicity and neuroprotection within the nucleus basalis of the rat
82. Basal forebrain lesions and memory alterations in neurotensin, not acetylcholine, may cause amnesia
83. Basal forebrain neurons and memory: a biochemical, histological and behavioral study of differential vulnerability to ibotenate and quisqualate
84. Basal forebrain cholinergic neurons and Alzheimer's disease
85. 2+ antagonize NMDA and GABA responses of hippocampal neurons
86. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides
87. Evidence that zinc inhibits N-methyl-d-aspartate receptor-gated ion channel activation by noncompetitive antagonism of glycine binding